Back to Search
Start Over
MEPOLIZUMAB REDUCES EXACERBATIONS, OCS AND COST AMONG PATIENTS WITH SEVERE ASTHMA AND THE HIGHEST EXPENDITURES PRIOR TO TREATMENT.
- Source :
- CHEST; 2021 Supplement, Vol. 160 Issue 4, pA1811-A1814, 4p
- Publication Year :
- 2021
- Subjects :
- ASTHMATICS
COST
Subjects
Details
- Language :
- English
- ISSN :
- 00123692
- Volume :
- 160
- Issue :
- 4
- Database :
- Complementary Index
- Journal :
- CHEST
- Publication Type :
- Academic Journal
- Accession number :
- 152845809
- Full Text :
- https://doi.org/10.1016/j.chest.2021.07.1636